IL-7-primed Bystander CD8 Tumor-Infiltrating Lymphocytes Optimize the Antitumor Efficacy of T Cell Engager Immunotherapy

Kun-Joo Lee,Donghoon Choi,Nara Tae,Ha Won Song,Yeon-Woo Kang,Minji Lee,Dain Moon,Youngsik Oh,Sujeong Park,Ji-Hae Kim, Siheon Jeong, Jaehyuk Yang, Uni Park, Da Hee Hong, Mi-Sun Byun,Su-Hyung Park,Joohyuk Sohn,Yunji Park,Sun-Kyoung Im,Sun Shim Choi,Dae Hee Kim,Seung-Woo Lee

CELL REPORTS MEDICINE（2024）

Cited 0|Views6

Key words

cancer immunotherapy,interleukin-7,bispecific T cell engager,combination therapy,solid tumors,bystander CD8 T cell,tumor microenvironment,tumor-infiltrating lymphocytes

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined